Shift workers showed an increase in stress hormone

Gang work or working odd hours can cause changes in stress hormone levels, unusually when people start these schedules as young adults, according to a new Dutch survey. Researchers said that increased levels of cortisol, a hormone whose levels grow when people are stressed, could be key to the development of serious constitution issues, including obesity, high blood pressure, diabetes and tenderness disease.
"Our findings show that cortisol capability play an important part in the development of obesity and increased cardiovascular risk for those working in shifts," leash author Dr. Laura Manenschijn, at Erasmus Medical Center in Rotterdam, said in an Endocrine Company news release. "Unraveling the role of cortisol in the vigour problems found in shift workers could result in new approaches to curb cardiovascular damage in this specific group."
In conducting the swatting, researchers took hair samples from 33 hours workers and 89 daytime workers to measure their cortisol levels. Researchers develop that long-term cortisol levels were significantly higher centre of shift workers, particularly those younger than 40.
Various Results Seen With 'Off-Label' Use of Antipsychotics
 Equal though off-label use of atypical antipsychotic drugs is common, a new review finds that such use is not effective in a few conditions and can be harmful in others. Also known as "favour-generation" antipsychotics, these drugs are approved in the United States for treatment of schizophrenia, bipolar tumult and depression.
But off-label use -- or use not approved by the U.S. Food and Drug Administration -- of these drugs to reception of a number of other conditions is growing. Researchers analyzed findings from 393 clinical studies to gauge effectiveness and uncover venomous side effects when Risperdal, Zyprexa, Seroquel, Abilify, Geodon, Saphris, Fanapt and Invega were inured to outside of FDA-approved indications.
Off-marker use included treatment for behavioral symptoms in dementia, uneasiness, depression, obsessive-compulsive disorder, eating disorders, pole-traumatic stress disorder, insomnia, personality disorders and reality abuse. The investigators found that to buy Valium, Abilify (aripiprazole), Zyprexa (olanzapine) and Risperdal (risperidone) were associated with negligible but statistically significant benefits for elderly people with dementia symptoms, such as combativeness, psychosis and mood changes.
Seroquel (quetiapine) was 26 percent more true belongings than placebo in people with generalized apprehension disorder, and Risperdal was four times more striking than placebo in people with obsessive-overwhelming disorder.
There was no confirmation that atypical antipsychotics benefited people with resources abuse or eating disorders, according to Dr. Alicia Ruelaz Maher, of RAND Healthiness in Santa Monica, Calif., and colleagues.
The researchers also build that certain atypical antipsychotics increased the risk of eradication, stroke, movement disorders and urinary tract symptoms in past middle age patients. In younger patients, some of the buy diazepam generic valium caused problems such as impact gain, fatigue, sedation, and akathisia, also known as reconversion leg syndrome.

Buy Levaquin Online

Zyban
Buy Depakote

Workplace Depression Screening, Enhanced Treatment Improves Productivity

Enhanced and systematic efforts to identify and treat depression in the workplace significantly improves employee health and productivity, likely leading to lower costs overall for the employer, according to a study published September 26, 2007, in the Journal of the American Medical Association. The study was funded by the National Institutes of Health’s National Institute of Mental Health (NIMH).
Previous studies have shown that employees who are depressed are less productive and are absent more often. Other studies have shown that organized screening and enhanced depression treatment can significantly improve health. However, few employers have implemented such programs, in part because their return on investment is unclear.
"This study provides compelling evidence of the importance of workplace depression screening, outreach, and enhanced treatment," said NIMH Director Thomas R. Insel, M.D. "It is in the interest of workers’ health and the company’s bottom line to ensure depressed employees are effectively treated."
Philip Wang, M.D., Dr.P.H., director of NIMH’s Division of Services and Intervention Research, and colleagues conducted a trial with 604 employees enrolled in a managed behavioral health care plan, all of whom were identified as having clinically significant depression during a Web-based and telephone screening process. Half of the participants were randomly assigned to an intervention that included telephone support from a care manager and their choice of telephone psychotherapy, in-person psychotherapy or antidepressant medication. The other half of the participants were assigned to usual care, which included feedback about their screening results, and advice to seek care from their usual provider.
After 12 months, those in the intervention group were 40 percent more likely to have recovered from their depression compared to those in usual care. Participants in the intervention group also were 70 percent more likely to stay employed, and worked an average of two more hours per week than those in usual care.
Although the data did not lend itself to a comprehensive cost/benefit analysis, the researchers noted that just the value of more hours worked among those in the intervention group who were employed, estimated at $1,800 per employee per year, far exceeds the $100-$400 per person costs associated with the type of outreach and intervention program used in the study.
"For many people, a large chunk of their lives is devoted to work. Depression affects not only a person’s health, but also his or her ability to work," noted Dr. Wang. "Employers should consider a depression screening and intervention program as a healthy, win-win investment."

Many Therapies Other Than Drugs Show Promise for Depression

A new Consumer Reports study this week has found that Americans prefer drugs to talk therapy for depression and that the most popular medications include the selective serotonin reuptake inhibitors, or SSRI’s. However, the 1500 survey participants also often report side-effects that go along with the drugs, including loss of sexual interest or ability.
Nearly 80% of those surveyed were prescribed antidepressants for depression symptoms. SSRI’s remain the most popular, including drugs such as Prozac (fluoxetine) by Eli Lilly, Zoloft (sertraline) by Pfizer, and Celexa (citalopram) or Lexapro (escitalopram) from Forest Laboratories. These drugs, however, were associated with more adverse side effects than newer medications such as Effexor (venlafaxine) and Cymbalta (duloxetine).
Read: Antidepressants May Have 20 Times More Side Effects Than Previously Thought
SSRI’s work by flooding the brain’s synapses with serotonin, a neurotransmitter linked with mood. They also increase the signaling of the brain’s serotonin receptors. By restoring a “chemical balance”, antidepressants help relieve symptoms such as sadness, hopelessness, and lack of interest in life.
“There are big drawbacks to the current therapies for depression,” says John Traynor PhD, a professor of pharmacology at the University of Michigan Medical School and author of a recent study in the Proceedings of the National Academy of Sciences. “Therapeutic benefits are delayed, there are unwanted side effects, and it’s not unusual for depressive symptoms to return.”
While antidepressants for some have brought great relief for mild to moderate depression symptoms, they are only one treatment option. (Antidepressants remain the most effective treatment for severe depression). Although the readers in the Consumer Reports survey preferred the drugs, many reported receiving just as much benefits from several sessions of talk therapy with a psychiatrist, psychologist, or social worker. The most common types of therapy for depression include cognitive behavioral therapy or cognitive restructuring.
Read: Internet Based Cognitive Therapy Can Treat Panic and Depressive Disorders
There are now numerous studies that show that exercise can improve mood and other depressive symptoms such as low energy and insomnia. Taking a walk outdoors has been shown to be especially effective for good mental health.
Read: The Magic Drug for Depression and Anxiety: Exercise and Five Minutes of Green Exercise Helps Maintain Good Mental Health
A healthy diet rich in B-vitamins and omega-3 fatty acids may have promise as an complementary therapy for depression. Some studies show that a deficiency in vitamin B12 (found in animal foods such as meat, dairy products and eggs) is linked to the worsening of depression symptoms and that an increased intake of fatty fish such as salmon and sardines may be a useful adjunct to other depression treatments. Dietary components to avoid include caffeine and alcohol.
Read: Can Vitamin D Help Seasonal Affective Disorder and Overindulging in Chocolate A Marker For Depression
Alternative therapies may also be beneficial in a comprehensive depression treatment plan. Acupuncture, an ancient healing remedy from China, may help improve mood and reduce feelings of fatigue, anxiety and bouts of insominia. Light therapy may be useful, specifically with those who suffer from seasonal affective disorder (SAD). Meditation and other relaxation techniques can also be a helpful addition to depression therapies by helping to relieve stress and reduce repetitive negative thoughts.